@inbook{93762,
  keywords = {Neglected tropical diseases (NTDs), Trachoma, Lymphatic filariasis (LF), onchocerciasis, schistosomiasis, Soil-transmitted helminthiasis (STH), mass drug administration (MDA)},
  author = {Fong I},
  title = {Mass Drug Treatment of Tropical Diseases: Is It Really Progress?},
  abstract = {There are 13 major chronic disabling diseases that are most common among the world’s poorest people, considered neglected tropical diseases that have been targeted by the World Health Organization for elimination or control. Five of the most prevalent of these (lymphatic filariasis, helminthiasis, onchocerciasis, schistosomiasis, and trachoma) have been treated by preventive chemotherapy given as mass drug treatment once or twice a year to endemic communities in tropical countries (mainly Africa and Asia) with some evidence of benefit. However, in the present era of widespread increasing global antimicrobial resistance directly related to their overuse, this policy may result in short-term gains but long-term pain from fuelling further drug resistance. This chapter reviews the current evidence of mass drug treatment of tropical diseases and potential disadvantages and concerns.},
  year = {2020},
  journal = {Current Trends and Concerns in Infectious Diseases},
  pages = {217-239},
  publisher = {Springer International Publishing},
  isbn = {9783030369651},
  doi = {10.1007/978-3-030-36966-8_9},
  language = {eng},
}